BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17166493)

  • 21. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
    Marino DJ; Starr TB
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):285-300. PubMed ID: 17949874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human biomonitoring assessment values: approaches and data requirements.
    Angerer J; Aylward LL; Hays SM; Heinzow B; Wilhelm M
    Int J Hyg Environ Health; 2011 Sep; 214(5):348-60. PubMed ID: 21764371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans.
    Dorne JL; Renwick AG
    Toxicol Sci; 2005 Jul; 86(1):20-6. PubMed ID: 15800035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical mixtures: evaluation of risk for child-specific exposures in a multi-stressor environment.
    Pohl HR; Abadin HG
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):116-25. PubMed ID: 18353412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical-specific adjustment factors for intraspecies variability of acetone toxicokinetics using a probabilistic approach.
    Mörk AK; Johanson G
    Toxicol Sci; 2010 Jul; 116(1):336-48. PubMed ID: 20400482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does gender really matter in contaminant exposure? A case study using invertebrate models.
    McClellan-Green P; Romano J; Oberdörster E
    Environ Res; 2007 May; 104(1):183-91. PubMed ID: 17097631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A new toxicological concept-acute reference dose].
    Liu Z; Chen B
    Wei Sheng Yan Jiu; 2003 Jan; 32(1):76-7, back cover. PubMed ID: 12731294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of the risk assessment of hazardous materials and the role of toxicology.
    Mattie DR
    Ann Clin Lab Sci; 1997; 27(3):173-8. PubMed ID: 9142368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment.
    Makris SL; Thompson CM; Euling SY; Selevan SG; Sonawane B
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):530-46. PubMed ID: 19085945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute inhalative exposure assessment: derivation of guideline levels with special regard to sensitive subpopulations and time scaling.
    Mielke H; Gundert A; Abraham K; Gundert-Remy U
    Toxicology; 2005 Oct; 214(3):256-67. PubMed ID: 16055256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of safety or uncertainty factors in the setting of acute reference doses.
    Renwick AG
    Food Addit Contam; 2000 Jul; 17(7):627-35. PubMed ID: 10983588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis of children's hand-to-mouth frequency data for estimating nondietary ingestion exposure.
    Xue J; Zartarian V; Moya J; Freeman N; Beamer P; Black K; Tulve N; Shalat S
    Risk Anal; 2007 Apr; 27(2):411-20. PubMed ID: 17511707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment factors for extrapolation from short-time to chronic exposure--are the REACH guidelines adequate?
    Malkiewicz K; Hansson SO; Rudén C
    Toxicol Lett; 2009 Oct; 190(1):16-22. PubMed ID: 19540321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular target sequence similarity as a basis for species extrapolation to assess the ecological risk of chemicals with known modes of action.
    Lalone CA; Villeneuve DL; Burgoon LD; Russom CL; Helgen HW; Berninger JP; Tietge JE; Severson MN; Cavallin JE; Ankley GT
    Aquat Toxicol; 2013 Nov; 144-145():141-54. PubMed ID: 24177217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the scientific foundation for mixtures joint toxicity and risk assessment: contributions from the SOT mixtures project--introduction.
    Mason AM; Borgert CJ; Bus JS; Moiz Mumtaz M; Simmons JE; Sipes IG;
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):99-103. PubMed ID: 17434550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How can toxicogenomics inform risk assessment?
    Oberemm A; Onyon L; Gundert-Remy U
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):592-8. PubMed ID: 15990130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of biokinetics in risk assessment of drugs and chemicals in children.
    de Zwart LL; Haenen HE; Versantvoort CH; Wolterink G; van Engelen JG; Sips AJ
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):282-309. PubMed ID: 15135209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. REACH, non-testing approaches and the urgent need for a change in mind set.
    Schaafsma G; Kroese ED; Tielemans EL; Van de Sandt JJ; Van Leeuwen CJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):70-80. PubMed ID: 19061930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using publicly available information to create exposure and risk-based ranking of chemicals used in the workplace and consumer products.
    Jayjock MA; Chaisson CF; Franklin CA; Arnold S; Price PS
    J Expo Sci Environ Epidemiol; 2009 Jul; 19(5):515-24. PubMed ID: 18685562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.